Filter Results
:
(185)
Show Results For
-
All HBS Web
(309)
- People (1)
- News (81)
- Research (185)
- Multimedia (3)
- Faculty Publications (123)
Show Results For
-
All HBS Web
(309)
- People (1)
- News (81)
- Research (185)
- Multimedia (3)
- Faculty Publications (123)
Sort by
- February 2008 (Revised August 2008)
- Case
EXACT Sciences Corp.: Commercializing a Diagnostic Test
This case addresses the challenges of commercializing molecular diagnostics. Along the way, it explains the technology, payment system, and the measures used to assess the value of a diagnostic test.
View Details
Keywords:
Health Testing and Trials;
Genetics;
Science-Based Business;
Commercialization;
Biotechnology Industry
Herzlinger, Regina E. "EXACT Sciences Corp.: Commercializing a Diagnostic Test." Harvard Business School Case 308-090, February 2008. (Revised August 2008.)
- 12 Nov 2015
- Research & Ideas
Can Consumers be Trusted with Their Own Health Care?
reveals a person’s genetically based health risk across dozens of disease categories. 23andMe test results showed one patient at higher risk of liver and bowel cancer—and that made sense, given family history. The patient discussed the...
View Details
- November 2006 (Revised March 2008)
- Case
The Harvard Stem Cell Institute
Describes a set of issues confronting the leaders of the Harvard Stem Cell Institute, an innovative cross-university effort to accelerate scientific discovery and translation in the domain of stem cells. Covers a wide range of topics, including understanding how...
View Details
Keywords:
Talent and Talent Management;
Higher Education;
Entrepreneurship;
Collaborative Innovation and Invention;
Intellectual Property;
Research and Development;
Genetics;
Biotechnology Industry;
Health Industry;
Massachusetts
Sahlman, William A. "The Harvard Stem Cell Institute." Harvard Business School Case 807-096, November 2006. (Revised March 2008.)
- 05 Dec 2013
- Op-Ed
Encourage Breakthrough Health Care by Competing on Products Rather Than Patents
Like many people interested in the tangled connections between health care progress and intellectual property rights, I avidly followed the Myriad Genetics case, decided by the Supreme Court this June 13. In sum, molecular diagnostics...
View Details
- 15 Jul 2008
- First Look
First Look: July 15, 2008
institute, The Broad Institute. The culture of the Broad centered on science, and those involved considered it to be at the edge of the scientific frontier. In just four years the Broad had made many important scientific contributions to the biomedical field. These...
View Details
Keywords:
Martha Lagace
- September 2019 (Revised August 2020)
- Case
Engineering an Inclusive Bioeconomy
By: Tarun Khanna, Raffaella Sadun and Susie L. Ma
In 2019, entrepreneur Juan Carlos Castilla-Rubio was developing a project he hoped could generate and share wealth from the natural resources of the Amazon without destroying those resources. His idea, called Earth Bank of Codes (EBC), would create a library of the...
View Details
Keywords:
Decision Making;
Development Economics;
Entrepreneurship;
Innovation and Invention;
Intellectual Property;
Emerging Markets;
Market Design;
Marketplace Matching;
Science;
Genetics;
Natural Environment;
Environmental Sustainability;
Climate Change;
Social Enterprise;
Strategy;
Strategic Planning;
Information Technology;
Ownership;
Social Psychology;
Trust;
Society;
Biotechnology Industry;
South America;
Amazon Basin
Khanna, Tarun, Raffaella Sadun, and Susie L. Ma. "Engineering an Inclusive Bioeconomy." Harvard Business School Case 720-356, September 2019. (Revised August 2020.)
- 06 Aug 2014
- What Do You Think?
What Is Warren Bennis’s Legacy?
as the father of leadership." In an extended remembrance that Bill sent to me, he went on to say that "It was Warren who first said leadership is not a set of genetic characteristics, but rather the result of the lifelong...
View Details
- October 1998 (Revised December 1999)
- Case
Gene Research, the Mapping of Life and the Global Economy
By: Ray A. Goldberg and Juan Enriquez-Cabot
A new firm is being created to speed up the process of mapping humans, animals, and plants by combining gene technology with rapid gene identification to improve the health and well being of the human population and the productivity of crops and animals. How does one...
View Details
Keywords:
Information Technology;
Organizational Structure;
Technological Innovation;
Business Processes;
Health Care and Treatment;
Performance Productivity;
Welfare;
Agribusiness;
Genetics;
Science-Based Business;
Biotechnology Industry;
Agriculture and Agribusiness Industry
Goldberg, Ray A., and Juan Enriquez-Cabot. "Gene Research, the Mapping of Life and the Global Economy." Harvard Business School Case 599-016, October 1998. (Revised December 1999.)
- June 2011 (Revised October 2013)
- Case
Gene Patents (A)
By: Richard Hamermesh, David Kiron and Phillip Andrews
In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our increasing knowledge of the Human Genome. The case issues...
View Details
Keywords:
Courts and Trials;
Patents;
Genetics;
Judgments;
Science-Based Business;
Biotechnology Industry;
United States
Hamermesh, Richard, David Kiron, and Phillip Andrews. "Gene Patents (A)." Harvard Business School Case 811-089, June 2011. (Revised October 2013.)
- November 2009 (Revised March 2010)
- Case
Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story
By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon
In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had...
View Details
Keywords:
Entrepreneurship;
Governing Rules, Regulations, and Reforms;
Health Testing and Trials;
Marketing Strategy;
Product Positioning;
Genetics;
Biotechnology Industry;
Europe;
United States
Hamermesh, Richard G., Raju Kucherlapati, and Rachel Gordon. "Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story." Harvard Business School Case 810-066, November 2009. (Revised March 2010.)
- 13 May 2014
- First Look
First Look: May 13
large cadre of data scientists who could develop and run programs to sift through the mountains of genetic data that were being generated every day. But the approach raised other questions. Could people trained in traditional fields of...
View Details
Keywords:
Sean Silverthorne
- 25 Feb 2014
- First Look
First Look: February 25
is based in Massachusetts and lists in London on AIM. Products are genetically modified fast-growing salmon for fish farmers and disease-prevention drugs and diagnostic kits for farmed shrimp. Purchase this case:...
View Details
Keywords:
Sean Silverthorne
- 26 Sep 2006
- First Look
First Look: September 26, 2006
share in the billion dollar DNA-synthesis market. Codon had several distinctive features for a company its size and age: it was already generating revenue from several different types of customer for its genetic products; it looked...
View Details
Keywords:
Sean Silverthorne
- 08 May 2012
- First Look
First Look: May 8
case updates events since the court's ruling against Myriad Genetics on March 29, 2010, and should be used in conjunction with "Gene Patents (A)." On July 29, 2011, a U.S. appeals court reversed the prior ruling against Myriad....
View Details
Keywords:
Carmen Nobel
- 17 Mar 2022
- Research & Ideas
Navigating Tradeoffs: How Purpose Becomes a Company's ‘Lighthouse in the Storm’
genetically modified corn to manufacture it, and only consumers in locations with municipal composting facilities could compost this packaging. Most of the company’s compostable plastic would wind up in landfills, or even worse, consumers...
View Details
Keywords:
by Ranjay Gulati
- 06 Feb 2007
- First Look
First Look: February 6, 2007
Industry Harvard Business School Case 507-021 ViaGen has invested heavily to develop cloning technology for the livestock industry. Cloning has the potential to significantly improve the genetics of livestock, leading to higher quality...
View Details
Keywords:
Martha Lagace
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
commercializing new biotechnology. This lack of technical capabilities led to two major acquisitions late in the twentieth century. In 1989 American Home Products acquired, for $666 million, 60 percent of the equity of the Genetics...
View Details
- 08 Jun 2021
- Research & Ideas
Tell Me What to Do: When Bad News Is a Big Relief
surgery for a genetic condition. “I was lying in the MRI thinking, ‘I hope they find just the shadow of something suspicious and bad because then the decision won’t be up to me,’” she says. “Afterward, I was like, ‘That’s the craziest,...
View Details
Keywords:
by Michael Blanding
- 22 Nov 2016
- First Look
November 22, 2016
and the University of California, Berkeley were in the middle of a contentious patent dispute over which entity controlled a breakthrough gene editing technology called CRISPR-Cas9. With CRISPR-Cas9, scientists might soon be able to cure previously incurable View Details
Keywords:
Sean Silverthorne
- 03 Aug 2010
- First Look
First Look: August 3
PublicationsLords of the Harvest: Symbolic Signaling and Regulatory Approval of Genetically Modified Organisms Authors:Shon R. Hiatt and Sangchan Park Publication:Best Paper Proceedings of the Academy of Management (2010) Abstract Firms...
View Details
Keywords:
Martha Lagace